| 000 | 01363 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250514031747.0 | ||
| 264 | 0 | _c20020620 | |
| 008 | 200206s 0 0 eng d | ||
| 022 | _a0029-6570 | ||
| 024 | 7 |
_a10.7748/ns.16.1.20.s38 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFoxton, J | |
| 245 | 0 | 0 |
_aStatin safety. _h[electronic resource] |
| 260 |
_bNursing standard (Royal College of Nursing (Great Britain) : 1987) _c |
||
| 300 |
_a20 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdverse Drug Reaction Reporting Systems |
| 650 | 0 | 4 |
_aCoronary Disease _xetiology |
| 650 | 0 | 4 |
_aDrug Monitoring _xmethods |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aDrug and Narcotic Control |
| 650 | 0 | 4 |
_aGemfibrozil _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xadverse effects |
| 650 | 0 | 4 |
_aHypercholesterolemia _xcomplications |
| 650 | 0 | 4 | _aPractice Guidelines as Topic |
| 650 | 0 | 4 |
_aPyridines _xadverse effects |
| 650 | 0 | 4 |
_aRhabdomyolysis _xchemically induced |
| 650 | 0 | 4 |
_aUnited Kingdom _xepidemiology |
| 650 | 0 | 4 |
_aUnited States _xepidemiology |
| 773 | 0 |
_tNursing standard (Royal College of Nursing (Great Britain) : 1987) _gvol. 16 _gno. 1 _gp. 20 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.7748/ns.16.1.20.s38 _zAvailable from publisher's website |
| 999 |
_c11878350 _d11878350 |
||